Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy
Campus News

Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy

By Will DossApr 12, 2021
Share
Facebook Twitter Email
Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, has received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Miller is among a group of scientists who designed and tested nanoparticles that induce gluten tolerance in celiac disease, findings that were published in the journal Gastroenterology.

“The study is the first demonstration that immune tolerance to gluten can be induced in humans with celiac using a ‘negative vaccine’ consisting of gluten encapsulated within nanoparticles which induces a regulatory immune response,” said Miller, who is also a professor of Dermatology, of Medicine in the Division of Gastroenterology and Hepatology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

About 1 percent of the population has celiac disease, a serious autoimmune disease in which the ingestion of gluten leads to damage in the small intestine. When people with celiac disease eat gluten — a protein found in wheat — their body mounts an immune response that attacks the small intestine.

Miller and his colleagues designed a biodegradable nanoparticle containing gluten that teaches the immune system that gluten is safe. The nanoparticle acts like a Trojan horse, hiding the allergen in a friendly shell to convince the immune system not to attack it.

After treatment with the technology, patients in the trial were able to eat gluten with a substantial reduction in inflammation, while patients in the untreated control group developed inflammation in the small intestine that is a characteristic of celiac disease.

Currently, there is no treatment for celiac disease, and doctors can only recommend gluten avoidance. This nanoparticle platform could be the key to a long-awaited treatment, not just for celiac disease but for other autoimmune and allergic diseases as well, according to Miller.

“Traditional treatments for autoimmune disease employ immunosuppressive drugs which lack specificity and make patients highly susceptible to infections and increase rates of cancer,” Miller said. “The clinical trial proved that the gluten-containing nanoparticles were safe and highly efficacious.”

The study was sponsored by COUR Pharmaceuticals Development and supported by Takeda Pharmaceuticals International.

The SFB is a multidisciplinary society of academic, healthcare, governmental and business professionals dedicated to promoting advancements in all aspects of biomaterial science, education and professional standards to enhance human health and quality of life.

Awards Faculty Gastroenterology Immunology Research
Share. Facebook Twitter Email

Related Posts

Feinberg Investigators Identify How a Residential Neighborhood Can Impact Health

Sep 22, 2023
Sep 22, 2023

Robert Lamb, Renowned Expert on Influenza Virus, Dies at 72

Sep 22, 2023

Bethany Ekesa, Associate Director of SPARC, Honored with Jean E. Shedd University Citizenship Award

Sep 21, 2023

Comments are closed.

Latest News

Feinberg Investigators Identify How a Residential Neighborhood Can Impact Health

Sep 22, 2023

Robert Lamb, Renowned Expert on Influenza Virus, Dies at 72

Sep 22, 2023

Bethany Ekesa, Associate Director of SPARC, Honored with Jean E. Shedd University Citizenship Award

Sep 21, 2023

Combination Immunotherapy Shows No Additional Benefit for Most Advanced Cancers

Sep 21, 2023

Novel Intracellular Signaling Mechanisms Promote Melanoma Growth

Sep 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230914_NM461
20230914_NM644
20230914_NM345
20230914_NM444
20230914_NM464
20230914_NM520
20230914_NM673
20230914_NM641
20230914_NM612
20230914_NM608
20230914_NM602
20230914_NM597

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.